20162017201820192020202120222023Billable/Specific Code
- E89.89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM E89.89 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E89.89 – other international versions of ICD-10 E89.89 may differ.
ICD-10-CM E89.89 is grouped within Diagnostic Related Group(s):
- 919 Complications of treatment with mcc
- 920 Complications of treatment with cc
- 921 Complications of treatment without cc/mcc
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E89.89:
- acquired > endocrine gland NEC (congenital) Q89.2
- specified NEC > postprocedural E89.6
- postoperative > metabolic E88.9
- specified NEC > postoperative E89.89
- endocrine > specified NEC I97.89
- metabolic > specified NEC I97.89
- metabolic > surgical procedure (on) T81.9
- specified NEC > metabolic E89.89
- postprocedural > endocrine E34.9
- specified NEC > postprocedural E89.89
- postprocedural > metabolism NOS E88.9
- specified NEC > postprocedural E89.89
